These findings suggest that ADAM12 mediates the shedding of the ectodomain of pro-HB-EGF in SIP, which then binds to EGFR and activates it, thereby establishing a signaling pathway that contributes to SIP tumor growth. The gene discussed is EGFR; the disease is neoplasm.